Lophora

About:

Lophora develops new rapid-acting drugs for central nervous system diseases including treatment-resistant depression.

Website: https://www.lophora.com/

Top Investors: BioInnovation Institute

Description:

Lophora develops new rapid-acting drugs for central nervous system diseases including treatment-resistant depression. Lophora has discovered and patented a new class of proprietary ligands with a similar pharmacological profile to psilocybin, which has demonstrated promising clinical results in the treatment of depression. Lophora's new drug class can be used to treat other CNS disorders such as anxiety, PTSD, and substance abuse.